Related Experiment Video
Updated: Mar 7, 2026

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome
Published on: September 27, 2024
Association between the hypertriglyceridemic waist phenotype and hyperuricemia: a cross-sectional study
Shuang Chen1, Xiaofan Guo1, Siyuan Dong2
1Department of Cardiology, The First Affiliated Hospital of China Medical University, 155 Nanjing North Street, Heping District, Shenyang, 110001, People's Republic of China.
The hypertriglyceridemic waist (HTGW) phenotype, characterized by increased waist circumference and triglycerides, is strongly linked to a higher prevalence of hyperuricemia. Monitoring uric acid levels is recommended for individuals with the HTGW phenotype.
Area of Science:
- Metabolic Health
- Cardiovascular Risk Factors
- Endocrinology
Background:
- Hypertriglyceridemic waist (HTGW) phenotype is associated with metabolic syndrome.
- Hyperuricemia is linked to cardiovascular and metabolic diseases.
- Understanding the relationship between HTGW and hyperuricemia is crucial for risk stratification.
Purpose of the Study:
- To investigate the association between the hypertriglyceridemic waist (HTGW) phenotype and hyperuricemia.
- To determine if the HTGW phenotype is an independent risk factor for hyperuricemia.
Main Methods:
- Cross-sectional study of 11,576 adults in China.
- HTGW phenotype defined by elevated waist circumference and triglyceride levels.
- Logistic regression analysis to assess the association with hyperuricemia.
Main Results:
- Prevalence of hyperuricemia was significantly higher in the HTGW group (25.9%) compared to the normal waist normal triglyceride group (6.1%).
- The HTGW phenotype was strongly associated with hyperuricemia (OR 6.09, 95% CI 5.18-7.17), even after adjustments.
- The association was stronger in men than in women.
Conclusions:
- The HTGW phenotype is significantly associated with hyperuricemia.
- HTGW phenotype may serve as a clinical marker for identifying individuals at high risk of hyperuricemia.
- Clinical monitoring of uric acid is advised for individuals with the HTGW phenotype.
More Related Videos
14:56Sample Preparation to Bioinformatics Analysis of DNA Methylation: Association Strategy for Obesity and Related Trait Studies
Published on: May 6, 2022
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
Related Concept Videos
Cholesterol: Significance and Regulation
Considering cholesterol and...
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Obesity
Atherosclerosis III: Management
Coronary Artery Disease I: Introduction
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion